Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Zhejiang Jingxin Pharmaceutical's strong financials, higher ...

Zhejiang Jingxin Pharmaceutical's strong financials, higher than average ROE, decent net income growth, and efficient reinvestment of earnings could potentially boost its stock value. Analysts expect earnings to gain momentum.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
1622 Views
Comment
Sign in to post a comment